menu
    • menu

    Company profile for Cipla

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we...
    Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission is to be a leading global healthcare company which uses technology and innovation to meet everyday needs of all patients. Since inception in 1935, caring has been at the core of everything we do at Cipla. For patients, caring is a promise that we will do whatever it takes to ensure they have continued access to the highest quality medicines at affordable prices; whether a disease affects millions or just a few hundreds.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ciplaindia-flag Flag
    Country
    Country
    India
    Address
    Address
    Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumba...
    Telephone
    Telephone
    +91 22 23082891 / 23095521
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cipla.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI Korea

    Not Confirmed

    envelop Contact Supplier

    CPhI Korea

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    "50 Years of Innovation: Mikart

    mic"50 Years of Innovation: Mikart's legacy and what's next in CDMO excellence"

    This week, SpeakPharma interviews Michael Kallelis, CEO of Mikart, a leading contract development and manufacturing organization (CDMO) celebrating its 50th anniversary in the pharmaceutical industry. Based in the United States, Mikart has built a reputation for technical expertise, flexible business terms, and specialized capabilities in pharmaceutical development services. In this exclusive interview, Kallelis discusses how Mikart maintains its competitive edge through its Pharmaceutical Development Services team, quality control framework, and commitment to customized business solutions. Kallelis also explores the company's focus on liquid suspensions manufacturing, driven by growing demand from aging populations and pediatric patients, and explains how Mikart balances traditional family business values with modern innovation. HIGHLIGHTS// celebrating its 50th anniversary/ reputation for technical expertise/ how Mikart maintains its competitive edge Mikart is celebrating 50 years in business this year — what are some of the major milestones that have shaped the company's journey? Over our 50-year history, we've celebrated many memorable milestones, but one of the most significant in recent years has been achieving our growth objectives. This success was driven by the strategic expansion of our Pharmaceutical Development Services team, the completion of full aggregate serialization in our packaging department, modernization of our IT systems, enhanced productivity, and our ability to attract both new and returning customers. HIGHLIGHTS// expansion of our Pharmaceutical Development Services team/ completion of full aggregate serialization/ attract both new and returning customers How has Mikart maintained its competitive edge in a constantly evolving pharmaceutical landscape? Our customers consistently tell us that what sets us apart is our technical expertise, high service level, and flexible, customized business terms. At the core of our competitiveness is our focus on Pharmaceutical Development Services (PDS). Mikart's PDS opinion leaders are actively engaged in business development and form early, collaborative relationships with our customers' technical teams. From the outset, our prospects and clients work directly with Mikart's experienced formulation chemists, analytical method developers, and process-oriented engineers to design robust, reproducible, and efficient processes. This hands-on development approach is supported by a comprehensive quality control testing framework — covering raw material testing, in-process checks, on-site microbiological testing, and in-house stability studies. Oversight is provided by our robust Quality Management System, managed by a dedicated Quality Assurance and Regulatory Affairs team. The result is disciplined problem-solving, timely FDA submissions, and a "right-first-time" philosophy that accelerates time-to-market. We operate with a strong sense of urgency and consistently deliver a high level of customer satisfaction. What truly differentiates Mikart is our commitment to customized business terms that eliminate common roadblocks seen with other CDMOs. Our secret sauce is our exceptional service and flexibility in helping our customers bring innovative medicines to patients. HIGHLIGHTS// technical expertise, high service level/ flexible, customized business terms/ comprehensive quality control testing framework/ dedicated Quality Assurance and Regulatory Affairs team/ timely FDA submissions/ accelerates time-to-market What capabilities or services does Mikart offer today that didn't exist 10 or 20 years ago? Mikart was an early leader in serialization, implementing full capabilities well ahead of the industry timeline. This proactive approach has kept our packaging team in high demand. We also upgraded our tablet compression equipment to enhance both speed and reliability. To support growing development needs, we invested in new lab-scale development equipment, unit dose cup filling, sachet packaging, low-humidity suites, and a brand-new suite dedicated to closed-system manufacturing of liquids and suspensions. Most recently, we launched a multi-million dollar expansion of our packaging lines to support higher-speed tablet filling, powder-in-bottle formats, and new liquid fill capabilities. HIGHLIGHTS// early leader in serialization/ upgraded our tablet compression equipment/ multi-million dollar expansion of our packaging lines Why are liquid suspensions becoming such a key focus, and how is Mikart positioned? Formulating suspensions is a complex process that requires specialized expertise and equipment. According to our customers, few mid-market CDMOs do it well — and Mikart is one of them. There is growing industry demand for high-quality suspension manufacturing, driven by the needs of the aging baby boomer population and pediatric patients. For both groups, swallowing tablets or capsules can be difficult, making oral liquid suspensions a more practical alternative. In addition to being easier to administer, suspensions offer pharmacological advantages and can improve dosing compliance. Enhanced flavoring techniques further improve the patient experience — especially for children and infants — by making medicines more palatable. HIGHLIGHTS// growing industry demand for high-quality suspension manufacturing/ suspensions offer pharmacological advantages/ improve dosing compliance How does Mikart balance tradition with innovation to meet modern customer demands? At Mikart, we work hard to preserve the values of a traditional family business, even as we continue to modernize. Our goal is to make every customer feel like they are our top priority. Each customer is supported by a dedicated project manager who serves as their primary point of contact, along with direct access to key team members across departments. This structure ensures our customers are never isolated from our subject matter experts and can get timely, accurate answers to their questions. We're also mindful of the "technology trap" — the tendency to pursue every new innovation at the expense of focus and efficiency. Instead, we rely on market data and customer trends to guide our investments, enabling us to concentrate our resources and capital on technologies that meet real market needs. HIGHLIGHTS// customer is supported by a dedicated project manager/ customers are never isolated from our subject matter experts/ we rely on market data and customer trends to guide our investments/ meet real market needs Looking ahead, what's in store for Mikart in the next 5-10 years? Mikart's strategic plan is now in full motion, and with the momentum we've built, 50 percent growth is within reach. This projection is backed by a strong pipeline of annual FDA filings, a growing customer base, and a robust portfolio of active Pharmaceutical Development Services projects. As we grow, we remain committed to delivering exceptional service and continuously evolving to meet the changing needs of our customers. With renewed political emphasis on domestic manufacturing for the US market, we are ideally positioned to support the rapid, cost-effective development and production of high-quality medicines here at home. As we approach our 50th anniversary in the CDMO industry, we celebrate our legacy and look forward with optimism to the opportunities ahead in the next 5 to 10 years. HIGHLIGHTS// 50 percent growth is within reach/ strong pipeline of annual FDA filings 

    Impressions: 2389

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence

    PharmaCompass
    17 Jul 2025
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaQuality, Reliability, TrustQuality, Reliability, Trust

    Quality, Reliability, Trust
    Quality, Reliability, Trust

    reelQuality, Reliability, Trust

    This PharmaReel highlights Rochem’s capabilities in sourcing and supplying Generic APIs and Excipients, driven by Quality, Reliability, and Trust through fully cGMP-compliant operations. With over 30 years of experience and 16 offices worldwide, Rochem continues to develop partnerships across the US, China, Europe, and South America.

    Impressions: 3148

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    During the second quarter (Q2) of 2025, contract development and manufacturing organizations (CDMOs) made substantial investments in specialized therapeutic manufacturing. The quarter also saw CDMOs pursue high-value, complex manufacturing niches, particularly in antibody-drug conjugates (ADCs), cell and gene therapies (CGTs) and oligonucleotides.Alongside these trends, Q2 also saw CDMOs strengthen their footprint in the United States amid concerns over rising tariffs and unpredictable trade policies being enforced by the Trump administration.Regeneron Pharmaceuticals committed over US$ 3 billion through a 10-year agreement with Fujifilm Diosynth Biotechnologies to nearly double its US manufacturing capacity for biologics. Under this agreement, Fujifilm will manufacture and supply drug products for Regeneron at its large-scale facility in Holly Springs, North Carolina.Thermo Fisher Scientific announced plans to invest an additional US$ 2 billion in the US over four years, reinforcing its manufacturing and R&D capabilities. With 64 facilities spread across 37 states, Thermo Fisher aims to bolster American innovation and competitiveness. Similarly, Piramal Pharma announced a US$ 90 million investment plan for expanding two facilities in the US, thereby bringing its total investment in the country to US$ 570 million. View CDMO Activity Tracker for Q2 2025 (Free Excel Available)Veranova, Carbogen lead ADC wave; Axplora doubles down on HPAPI production in ItalyThe quarter saw substantial investments in ADC manufacturing. Veranova announced a US$ 20 million investment in bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. With this investment, Veranova will be able to provide a more comprehensive suite of services to its partners developing ADCs and other bioconjugates. Veranova’s total investment in the Devens facility now stands at over US$ 50 million. Swiss CDMO Carbogen announced a US$ 31 million co-investment with an unnamed Japanese investor to expand its capabilities across its Aarau and Neuland (Switzerland) facilities. The facility will address increasing demand for complex and high-value compounds such as ADC drug linkers.Axplora announced a further €35 million (US$ 41 million) expansion of its Farmabios site in Italy, doubling the facility to approximately 108,000 square meters by mid-2026. This investment raises its total spend on the site to over €80 million (US$ 94.05 million) since 2019, supporting the production of highly potent active pharmaceutical ingredients (HPAPIs). Farmabios now stands as a key hub in Axplora’s global CDMO network.Polish pharmaceutical manufacturer Polfa Tarchomin is positioning itself as a significant player in the European CDMO market through its investment in the Center for Development and Production of Highly Potent Drugs. This 12,000 square meter facility has two state-of-the-art production lines designed for filling vials and pre-filled syringes with an annual capacity of 26 million product units.Skyepharma’s projected annual revenues from oncology-linked activities touched €10 million (US$ 11.2 million). The CDMO’s facility in Saint-Quentin-Fallavier is equipped to handle cytotoxic and cytostatic compounds, and is one of the few facilities in France capable of managing HPAPIs for oral anticancer treatments. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Athena acquires Medipha Santé, Famar buys MiP Pharma’s German site to strengthen European footprintDuring the quarter, several CDMOs enhanced their strategic capabilities through M&As. Athena Pharmaceutiques acquired  Medipha Santé to build a fully integrated pharmaceutical services platform in Europe. Based in Paris, Athena has strengthened its commercial and regulatory toolbox by bringing aboard Medipha Santé’s 35-strong team, which supports over 100 partner organizations and files approximately 350 dossiers annually with ANSM and other European agencies. With this integration, Athena positions itself as a one-stop CDMO partner.With the acquisition of MiP Pharma’s sterile manufacturing site in Homburg, Germany, the Famar Group has expanded its capabilities in aseptic and lyophilized fill-and-finish operations. The acquisition has strengthened Famar’s position in sterile drug manufacturing. The CDMO now has seven manufacturing facilities in Europe.PCI Pharma Services’ acquisition of Ajinomoto Althea has established a world-class, large-scale manufacturing hub in the San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high-potent formulations such as ADCs. PCI Pharma is now amongst the few US-based CDMOs capable of comprehensive ADC manufacturing.Samsung Biologics’ strategic spinoff of its biosimilar business stood out as a significant corporate restructuring exercise during the quarter. The separation of Samsung Bioepis, tentatively renamed Samsung Epis Holdings, aims to enhance Samsung Biologics’ strategic focus and build client trust, as it eliminates potential conflicts between CDMO services and proprietary drug development. The move came after Samsung Biologics inked a contract worth 737.3 billion Korean won (US$ 518 million) with an undisclosed US pharmaceutical company.WuXi Biologics announced a US$ 167 million divestment of its German facility to Terumo and broke ground on a microbial production plant in China. National Resilience, which was launched five years ago as the US drug manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains, said it is shuttering six of its 10 facilities. The company said the sites were “not being fully utilized.” View CDMO Activity Tracker for Q2 2025 (Free Excel Available) MilliporeSigma, Simtra form 5-year ADC alliance; Silexion partners Catalent for siRNA developmentMerck KGaA’s MilliporeSigma and Simtra struck a five-year strategic alliance, combining expertise across the ADC value chain to reduce development timelines and complexity for biopharmaceutical companies. Viralgen collaborated with Trogenix to rapidly scale product supply for TGX-007, an AAV gene therapy for glioblastoma (a type of cancer of the brain and spinal cord).  Silexion announced a collaboration with Catalent for small interfacing RNA (siRNA) development and manufacturing. Catalent’s Limoges (France) facility will conduct formulation development and clinical manufacturing for Silexion’s SIL204 candidate, supporting both systemic and intra-tumoral delivery formulations.Skyepharma’s collaboration with Eneapharm through the Skyehub platform aims to support the treatment of patients suffering from exocrine pancreatic insufficiency, including those affected by cystic fibrosis or pancreatic cancer. Orion Corporation reached an agreement with Shilpa Biocare for the distribution of recombinant human albumin in Europe.Meanwhile, Aenova announced the launch of its Aenovation program, an initiative designed to fast-track early development of pharmaceutical formulations. The program addresses the critical challenges of bioavailability and time-to-market faced by poorly soluble drug candidates. View CDMO Activity Tracker for Q2 2025 (Free Excel Available) Our view The quarter saw CDMO developments mimic the broader trends in the pharmaceutical industry, such as onshoring of critical manufacturing capabilities in the US, consolidation of specialized expertise through strategic partnerships, and the relentless focus on emerging therapeutic modalities that promise to transform patient care. With CDMOs continuing to invest in next-generation manufacturing capabilities, we expect the sector to play a crucial role in drug innovation. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 7304

    https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint

    #PharmaFlow by PHARMACOMPASS
    10 Jul 2025
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Nectar Lifesciences Unit VI Earns CGMP Certification from SMDC
    Nectar Lifesciences Unit VI Earns CGMP Certification from SMDC

    12 Aug 2025

    // EQUITYBILL

    https://www.equitybulls.com/category.php?id=360642

    EQUITYBILL
    12 Aug 2025
    Share Share
    Enforcement Report - Week of July 30, 2025
    Enforcement Report - Week of July 30, 2025

    30 Jul 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-30-2025-84785.pdf

    FDA
    30 Jul 2025
    Share Share
    Cipla Targets $1 Bn Us Revenue in FY27
    Cipla Targets $1 Bn Us Revenue in FY27

    25 Jul 2025

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-targets-1-bn-us-revenue-in-fy27/articleshow/122909867.cms

    ECONOMICTIMES
    25 Jul 2025
    Share Share
    Cipla Invests in iCaltech to Boost Respiratory Sector
    Cipla Invests in iCaltech to Boost Respiratory Sector

    23 Jul 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/cipla-to-invest-in-icaltech-to-strengthen-respiratory-play-17458

    INDPHARMAPOST
    23 Jul 2025
    Share Share
    Cipla Invests in iCaltech for Stronger Respiratory Focus
    Cipla Invests in iCaltech for Stronger Respiratory Focus

    22 Jul 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cipla-invests-in-icaltech-innovations-to-strengthen-respiratory-play/

    EXPRESSPHARMA
    22 Jul 2025
    Share Share
    Cipla’s Generics Selenious Acid Receives Approval in US
    Cipla’s Generics Selenious Acid Receives Approval in US

    21 Jul 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218661

    FDA
    21 Jul 2025
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Celecoxib

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Celecoxib

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2013-09-28

    Pay. Date : 2013-09-20

    DMF Number : 16671

    Submission : 2003-06-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-186 - Rev 01

    Issue Date : 2023-05-30

    Type : Chemical

    Substance Number : 2591

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 230MF10110

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2018-08-20

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7533

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Ildong Pharmaceutical Co., Ltd.

    Registration Date : 2020-09-08

    Registration Number : 20190104-209-J-128(4)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : D-7, MIDC, Industrial Area, Kurkumbh, Taluka Daund, Pune 413 802, Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Risedronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Risedronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 20162

    Submission : 2007-03-16

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2014-130 - Rev 00

    Issue Date : 2020-04-28

    Type : Chemical

    Substance Number : 2572

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 223MF10141

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2011-09-07

    Latest Date of Registration :

    EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7653

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Amlodipine Besylate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Amlodipine Besylate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-03-17

    Pay. Date : 2017-03-06

    DMF Number : 17032

    Submission : 2003-12-17

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-067 - Rev 01

    Issue Date : 2014-07-28

    Type : Chemical

    Substance Number : 1491

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 221MF10131

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2009-06-30

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7561

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (35kg/35kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Boehringer Ingelheim Korea Ltd.

    Registration Date : 2021-11-05

    Registration Number : 20101029-130-H-18-03(4)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : Virgonagar Post, Old Madras Road, Bangalore-560 049, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Etoposide

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Etoposide

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 10642

    Submission : 1993-12-30

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2007-061 - Rev 06

    Issue Date : 2024-09-17

    Type : Chemical

    Substance Number : 823

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10214

    Registrant's Address : Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai - 400 013, INDIA

    Initial Date of Registration : 2010-08-05

    Latest Date of Registration :

    EU-WCInactive-api
    ✖

    Date of Issue : 2022-06-20

    Valid Till : 2025-08-08

    Written Confirmation Number : WC-0113

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7514

    Start Marketing Date : 2018-07-13

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (4kg/4kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Alendronate Sodium

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Alendronate Sodium

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2019-12-15

    Pay. Date : 2019-12-11

    DMF Number : 14334

    Submission : 1999-08-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-126 - Rev 04

    Issue Date : 2018-08-29

    Type : Chemical

    Substance Number : 1564

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7525

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Escitalopram Oxalate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Escitalopram Oxalate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2021-10-05

    Pay. Date : 2021-09-30

    DMF Number : 16636

    Submission : 2003-06-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-099 - Rev 01

    Issue Date : 2024-03-11

    Type : Chemical

    Substance Number : 2733

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-05

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0143n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7565

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : UNUST Co., Ltd.

    Registration Date : 2021-06-22

    Registration Number : 20210622-209-J-1030

    Manufacturer Name : Cipla Limited

    Manufacturer Address : Plot No. A-42, MIDC, Patalganga, Raigad 410220 Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Finasteride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Finasteride

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 15778

    Submission : 2001-12-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2005-025 - Rev 05

    Issue Date : 2022-04-12

    Type : Chemical

    Substance Number : 1615

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-05

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0143n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7714

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Hiple Co., Ltd.

    Registration Date : 2021-03-12

    Registration Number : 20071228-94-E-57-03(9)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : A-33 & A-37/2/2, MIDC Patalganga - 410 220, District Raigad, Maharashtra, State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Fluticasone Propionate

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Fluticasone Propionate

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-08-25

    Pay. Date : 2014-08-14

    DMF Number : 15774

    Submission : 2001-12-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2012-001 - Rev 02

    Issue Date : 2022-03-14

    Type : Chemical

    Substance Number : 1750

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7531

    Start Marketing Date : 1999-06-17

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Meloxicam

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Meloxicam

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2017-09-06

    Pay. Date : 2017-08-21

    DMF Number : 17148

    Submission : 2004-02-06

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2009-040 - Rev 05

    Issue Date : 2022-11-04

    Type : Chemical

    Substance Number : 2373

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-06-08

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0144nA2

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7574

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : Pharmapia Co., Ltd.

    Registration Date : 2024-12-23

    Registration Number : 20121010-148-I-54-04(12)

    Manufacturer Name : Cipla Limited

    Manufacturer Address : D-7 MIDC industrial Area, Kurkumbh, Taluka Daund, District : Pune, Maharashtra State, India

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Praziquantel

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    ACS Fall 2025
    Not Confirmed
    arrow

    Praziquantel

    India

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    ACS Fall 2025
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 14352

    Submission : 1999-08-19

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-081 - Rev 03

    Issue Date : 2017-05-22

    Type : Chemical

    Substance Number : 855

    Status : Valid

     JDMF EU-WCarrow-down
    ✖

    Date of Issue : 2022-07-05

    Valid Till : 2025-09-08

    Written Confirmation Number : WC-0143n

    Address of the Firm :

    NDC arrow-down
    ✖

    NDC Package Code : 53104-7567

    Start Marketing Date : 2016-01-01

    End Marketing Date : 2025-12-31

    Dosage Form (Strength) : POWDER (25kg/25kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    EU WC

    read-more
    read-more

    01

    Abacavir Sulfate USP

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    02

    Abacavir Sulfate BP/Ph. Eur

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    03

    Abiraterone Acetate

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    04

    Albendazole USP

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    05

    Alendronate Sodium Trihydrat...

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    06

    Ambrisentan IH

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    07

    Amlodipine Besylate Ph. Eur

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    08

    Amlodipine Besylate BP

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    09

    Amlodipine Mesylate Monohydr...

    India
    ACS Fall 2025
    Not Confirmed
    arrow

    10

    Anagrelide Hydrochloride Mon...

    India
    ACS Fall 2025
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Cipla and get a quotation

    Cipla is a supplier offers 334 products (APIs, Excipients or Intermediates).

    Find a price of Celecoxib bulk with DMF, CEP, JDMF, WC offered by Cipla

    Find a price of Risedronate Sodium bulk with DMF, CEP, JDMF, WC offered by Cipla

    Find a price of Amlodipine Besylate bulk with DMF, CEP, JDMF offered by Cipla

    Find a price of Etoposide bulk with DMF, CEP, JDMF offered by Cipla

    Find a price of Alendronate Sodium bulk with DMF, CEP, WC offered by Cipla

    Find a price of Budesonide bulk with DMF, CEP, WC offered by Cipla

    Find a price of Escitalopram Oxalate bulk with DMF, CEP, WC offered by Cipla

    Find a price of Finasteride bulk with DMF, CEP, WC offered by Cipla

    Find a price of Fluticasone Propionate bulk with DMF, CEP, WC offered by Cipla

    Find a price of Formoterol Fumarate bulk with DMF, CEP, WC offered by Cipla

    Find a price of Meloxicam bulk with DMF, CEP, WC offered by Cipla

    Find a price of Oseltamivir Phosphate bulk with DMF, JDMF, WC offered by Cipla

    Find a price of Praziquantel bulk with DMF, CEP, WC offered by Cipla

    Find a price of Ramipril bulk with DMF, CEP, WC offered by Cipla

    Find a price of Abacavir Sulfate bulk with DMF, CEP offered by Cipla

    Find a price of Anastrozole bulk with DMF, CEP offered by Cipla

    Find a price of Beclomethasone Dipropionate bulk with CEP, WC offered by Cipla

    Find a price of Bicalutamide bulk with DMF, CEP offered by Cipla

    Find a price of Carvedilol bulk with CEP, WC offered by Cipla

    Find a price of Cetirizine Dihydrochloride bulk with DMF, CEP offered by Cipla

    Find a price of Citalopram Hydrobromide bulk with CEP, WC offered by Cipla

    Find a price of Desloratadine bulk with CEP, WC offered by Cipla

    Find a price of Efinaconazole bulk with DMF, JDMF offered by Cipla

    Find a price of Esomeprazole Magnesium bulk with DMF, CEP offered by Cipla

    Find a price of Exemestane bulk with DMF, CEP offered by Cipla

    Find a price of Felodipine bulk with DMF, CEP offered by Cipla

    Find a price of Fluconazole bulk with CEP, WC offered by Cipla

    Find a price of Gefitinib bulk with DMF, CEP offered by Cipla

    Find a price of Granisetron Hydrochloride bulk with DMF, CEP offered by Cipla

    Find a price of Imatinib Mesylate bulk with DMF, CEP offered by Cipla

    Find a price of Lamivudine bulk with DMF, CEP offered by Cipla

    Find a price of Lamotrigine bulk with DMF, CEP offered by Cipla

    Find a price of Leflunomide bulk with DMF, CEP offered by Cipla

    Find a price of Letrozole bulk with DMF, CEP offered by Cipla

    Find a price of Mometasone Furoate bulk with CEP, WC offered by Cipla

    Find a price of Omeprazole bulk with DMF, CEP offered by Cipla

    Find a price of Pantoprazole Sodium bulk with DMF, CEP offered by Cipla

    Find a price of Pirfenidone bulk with DMF, CEP offered by Cipla

    Find a price of Pramipexole Dihydrochloride bulk with CEP, WC offered by Cipla

    Find a price of Risperidone bulk with DMF, CEP offered by Cipla

    Find a price of Rivastigmine Tartrate bulk with DMF, CEP offered by Cipla

    Find a price of Rizatriptan Benzoate bulk with CEP, WC offered by Cipla

    Find a price of Salbutamol Sulphate bulk with DMF, CEP offered by Cipla

    Find a price of Solifenacin Succinate bulk with DMF, CEP offered by Cipla

    Find a price of Terbinafine Hydrochloride bulk with DMF, CEP offered by Cipla

    Find a price of Trimetazidine Hydrochloride bulk with DMF, CEP offered by Cipla

    Find a price of Venlafaxine Hydrochloride bulk with CEP, WC offered by Cipla

    Find a price of Abiraterone Acetate bulk with JDMF offered by Cipla

    Find a price of Arformoterol Tartrate bulk with DMF, WC offered by Cipla

    Find a price of Atazanavir Sulfate bulk with DMF, WC offered by Cipla

    Find a price of Beclomethasone Dipropionate bulk with DMF, WC offered by Cipla

    Find a price of Ciclesonide bulk with CEP, WC offered by Cipla

    Find a price of Cinacalcet Hydrochloride bulk with DMF, WC offered by Cipla

    Find a price of Cyproterone Acetate bulk with CEP offered by Cipla

    Find a price of Darunavir Ethanolate bulk with DMF, WC offered by Cipla

    Find a price of Entecavir bulk with DMF, CEP offered by Cipla

    Find a price of Escitalopram Oxalate bulk with DMF, CEP offered by Cipla

    Find a price of Famciclovir bulk with DMF, WC offered by Cipla

    Find a price of Fluticasone Propionate bulk with DMF, CEP offered by Cipla

    Find a price of Levocetirizine Dihydrochloride bulk with DMF, WC offered by Cipla

    Find a price of Mebendazole bulk with DMF, WC offered by Cipla

    Find a price of Nevirapine bulk with DMF offered by Cipla

    Find a price of Olanzapine bulk with WC offered by Cipla

    Find a price of Omeprazole Sodium bulk with CEP offered by Cipla

    Find a price of Ondansetron Hydrochloride bulk with DMF, CEP offered by Cipla

    Find a price of Rivaroxaban bulk with DMF, CEP offered by Cipla

    Find a price of Salbutamol Sulphate bulk with CEP offered by Cipla

    Find a price of Salmeterol Xinafoate bulk with CEP offered by Cipla

    Find a price of Tamsulosin bulk with CEP offered by Cipla

    Find a price of Tiotropium Bromide bulk with CEP, WC offered by Cipla

    Find a price of Valganciclovir Hydrochloride bulk with DMF, WC offered by Cipla

    Find a price of Albendazole bulk with WC offered by Cipla

    Find a price of Ambrisentan bulk with DMF offered by Cipla

    Find a price of Amlodipine Besylate bulk with CEP offered by Cipla

    Find a price of Anagrelide Hydrochloride bulk with DMF offered by Cipla

    Find a price of Apremilast bulk with DMF offered by Cipla

    Find a price of Artemether bulk with WC offered by Cipla

    Find a price of Artesunate bulk with WC offered by Cipla

    Find a price of Bosentan Hydrate bulk with DMF offered by Cipla

    Find a price of Capecitabine bulk offered by Cipla

    Find a price of Carboplatin bulk with CEP offered by Cipla

    Find a price of Citalopram Hydrobromide bulk with DMF offered by Cipla

    Find a price of Citalopram Hydrobromide bulk with WC offered by Cipla

    Find a price of Danazol bulk with DMF offered by Cipla

    Find a price of Darifenacin Hydrobromide bulk with DMF offered by Cipla

    Find a price of Darunavir bulk with DMF offered by Cipla

    Find a price of Deferasirox bulk with DMF offered by Cipla

    Find a price of Dolutegravir Sodium bulk with DMF offered by Cipla

    Find a price of Dutasteride bulk offered by Cipla

    Find a price of Efavirenz bulk with DMF offered by Cipla

    Find a price of Eliglustat bulk with DMF offered by Cipla

    Find a price of Empagliflozin bulk with DMF offered by Cipla

    Find a price of Emtricitabine bulk with DMF offered by Cipla

    Find a price of Erlotinib Hydrochloride bulk with DMF offered by Cipla

    Find a price of Finasteride bulk offered by Cipla

    Find a price of Granisetron bulk with DMF offered by Cipla

    Find a price of Ipratropium Bromide bulk offered by Cipla

    Find a price of Irinotecan Hydrochloride bulk offered by Cipla

    Find a price of Lansoprazole bulk with CEP offered by Cipla

    Find a price of Lenalidomide bulk with DMF offered by Cipla

    Find a price of Lopinavir bulk with DMF offered by Cipla

    Find a price of Lumefantrine bulk with WC offered by Cipla

    Find a price of Montelukast Sodium bulk with DMF offered by Cipla

    Find a price of Nintedanib Esylate bulk with DMF offered by Cipla

    Find a price of Omeprazole bulk with DMF offered by Cipla

    Find a price of Oxaliplatin bulk with CEP offered by Cipla

    Find a price of Palonosetron bulk with DMF offered by Cipla

    Find a price of Pazopanib Hydrochloride bulk with DMF offered by Cipla

    Find a price of Ritonavir bulk with DMF offered by Cipla

    Find a price of Salbutamol Sulphate bulk with DMF offered by Cipla

    Find a price of Telmisartan bulk with DMF offered by Cipla

    Find a price of Tenofovir Alafenamide Fumarate bulk with DMF offered by Cipla

    Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Cipla

    Find a price of Topiramate bulk with DMF offered by Cipla

    Find a price of Valacyclovir Hydrochloride bulk with DMF offered by Cipla

    Find a price of Venlafaxine Hydrochloride bulk with CEP offered by Cipla

    Find a price of Vinblastine Sulfate bulk offered by Cipla

    Find a price of Vincristine Sulfate bulk offered by Cipla

    Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Cipla

    Find a price of Zidovudine bulk with DMF offered by Cipla

    Find a price of Zoledronic Acid bulk with WC offered by Cipla

    Find a price of Abiraterone Acetate bulk with DMF offered by Cipla

    Find a price of Acalabrutinib bulk with DMF offered by Cipla

    Find a price of Albendazole bulk with DMF offered by Cipla

    Find a price of Alfuzosin HCl bulk offered by Cipla

    Find a price of Alosetron Hydrochloride bulk with DMF offered by Cipla

    Find a price of Amlodipine Mesylate bulk offered by Cipla

    Find a price of Apixaban bulk with DMF offered by Cipla

    Find a price of Atazanavir Sulfate bulk with DMF offered by Cipla

    Find a price of Azelastine Hydrochloride bulk offered by Cipla

    Find a price of Bictegravir Sodium bulk with DMF offered by Cipla

    Find a price of Brexpiprazole bulk with DMF offered by Cipla

    Find a price of Budesonide bulk with CEP offered by Cipla

    Find a price of Cabotegravir bulk with DMF offered by Cipla

    Find a price of Cabotegravir Sodium bulk with DMF offered by Cipla

    Find a price of CAS 103639-04-9 bulk with WC offered by Cipla

    Find a price of CAS No 1613220-15-7 bulk with DMF offered by Cipla

    Find a price of Cetirizine bulk with WC offered by Cipla

    Find a price of Ciprofloxacin Hydrochloride bulk offered by Cipla

    Find a price of Cisplatin bulk with CEP offered by Cipla

    Find a price of Daclatasvir bulk offered by Cipla

    Find a price of Daprodustat bulk with DMF offered by Cipla

    Find a price of Dasatinib bulk with DMF offered by Cipla

    Find a price of Deucravacitinib bulk with DMF offered by Cipla

    Find a price of Difelikefalin Acetate bulk with DMF offered by Cipla

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by Cipla

    Find a price of Donepezil bulk with DMF offered by Cipla

    Find a price of Edaravone bulk with DMF offered by Cipla

    Find a price of Ensifentrine bulk with DMF offered by Cipla

    Find a price of Entecavir Monohydrate bulk with WC offered by Cipla

    Find a price of Enzalutamide bulk with DMF offered by Cipla

    Find a price of Fexofenadine Hydrochloride bulk offered by Cipla

    Find a price of Fluconazole bulk with DMF offered by Cipla

    Find a price of Flutamide bulk offered by Cipla

    Find a price of Fluticasone Furoate bulk with DMF offered by Cipla

    Find a price of Fluticasone Propionate bulk with CEP offered by Cipla

    Find a price of Gemcitabine bulk offered by Cipla

    Find a price of Icatibant Acetate bulk with DMF offered by Cipla

    Find a price of Indacaterol Acetate bulk with DMF offered by Cipla

    Find a price of Isavuconazonium Sulfate bulk with DMF offered by Cipla

    Find a price of Ivacaftor bulk with DMF offered by Cipla

    Find a price of Levalbuterol Hydrochloride bulk with DMF offered by Cipla

    Find a price of Levalbuterol Sulfate bulk offered by Cipla

    Find a price of Levofloxacin bulk with DMF offered by Cipla

    Find a price of Levonorgestrel bulk with DMF offered by Cipla

    Find a price of Losartan Potassium bulk offered by Cipla

    Find a price of Mirabegron bulk with DMF offered by Cipla

    Find a price of Mitoxantrone bulk offered by Cipla

    Find a price of Mometasone Furoate bulk with DMF offered by Cipla

    Find a price of Nateglinide bulk offered by Cipla

    Find a price of Nilotinib bulk with DMF offered by Cipla

    Find a price of Nirmatrelvir bulk with DMF offered by Cipla

    Find a price of Norfloxacin bulk offered by Cipla

    Find a price of Olaparib bulk with DMF offered by Cipla

    Find a price of Omeprazole Magnesium bulk with CEP offered by Cipla

    Find a price of Ondansetron bulk with WC offered by Cipla

    Find a price of Paliperidone bulk offered by Cipla

    Find a price of Pioglitazone Hydrochloride bulk with DMF offered by Cipla

    Find a price of Pomalidomide bulk with DMF offered by Cipla

    Find a price of Potassium Dihydrogen Phosphate bulk with DMF offered by Cipla

    Find a price of Pregabalin bulk offered by Cipla

    Find a price of Relugolix bulk with DMF offered by Cipla

    Find a price of Resmetirom bulk with DMF offered by Cipla

    Find a price of Revefenacin bulk with DMF offered by Cipla

    Find a price of Rilpivirine bulk with DMF offered by Cipla

    Find a price of Rilpivirine Hydrochloride bulk with DMF offered by Cipla

    Find a price of Rizatriptan Benzoate bulk with DMF offered by Cipla

    Find a price of Ruxolitinib Phosphate bulk with DMF offered by Cipla

    Find a price of Salmeterol Xinafoate bulk with DMF offered by Cipla

    Find a price of Saxagliptin Hydrochloride bulk offered by Cipla

    Find a price of Sertraline Hydrochloride bulk offered by Cipla

    Find a price of Siponimod bulk with DMF offered by Cipla

    Find a price of Sodium Thiosulfate bulk with DMF offered by Cipla

    Find a price of Sorafenib bulk with DMF offered by Cipla

    Find a price of Sorafenib bulk offered by Cipla

    Find a price of Sumatriptan bulk offered by Cipla

    Find a price of Tafamidis bulk with DMF offered by Cipla

    Find a price of Temozolomide bulk offered by Cipla

    Find a price of Tolterodine Tartrate bulk with DMF offered by Cipla

    Find a price of Umeclidinium Bromide bulk with DMF offered by Cipla

    Find a price of Vilanterol Trifenatate bulk with DMF offered by Cipla

    Find a price of Vinorelbine Tartrate bulk offered by Cipla

    Find a price of Zolpidem Tartrate bulk offered by Cipla

    Find a price of Salbutamol sulfate, Process III, Non-micronised and Micronised bulk with CEP offered by Cipla

    Find a price of Abacavir Sulfate bulk offered by Cipla

    Find a price of Acyclovir bulk offered by Cipla

    Find a price of Adefovir Dipivoxil bulk offered by Cipla

    Find a price of Alprazolam bulk offered by Cipla

    Find a price of Androsterone bulk offered by Cipla

    Find a price of Aripiprazole bulk offered by Cipla

    Find a price of Bortezomib bulk offered by Cipla

    Find a price of CAS 120011-70-3 bulk offered by Cipla

    Find a price of Celecoxib bulk offered by Cipla

    Find a price of Cetirizine bulk offered by Cipla

    Find a price of Clonidine bulk offered by Cipla

    Find a price of Clopidogrel bulk offered by Cipla

    Find a price of Danazol bulk offered by Cipla

    Find a price of Darunavir bulk offered by Cipla

    Find a price of Darunavir Ethanolate bulk offered by Cipla

    Find a price of Deferiprone bulk offered by Cipla

    Find a price of Desloratadine bulk offered by Cipla

    Find a price of Didanosine bulk offered by Cipla

    Find a price of Docetaxel bulk offered by Cipla

    Find a price of Donepezil bulk offered by Cipla

    Find a price of Doxazosin Mesylate bulk offered by Cipla

    Find a price of Drospirenone bulk offered by Cipla

    Find a price of Efinaconazole bulk offered by Cipla

    Find a price of Eliglustat bulk offered by Cipla

    Find a price of Emtricitabine bulk offered by Cipla

    Find a price of Esomeprazole Magnesium bulk offered by Cipla

    Find a price of Etoposide bulk offered by Cipla

    Find a price of Exemestane bulk offered by Cipla

    Find a price of Felodipine bulk offered by Cipla

    Find a price of Ibrutinib bulk offered by Cipla

    Find a price of Ibuprofen bulk offered by Cipla

    Find a price of Imatinib Mesylate bulk offered by Cipla

    Find a price of Imiquimod bulk offered by Cipla

    Find a price of Irbesartan bulk offered by Cipla

    Find a price of Ivabradine Hydrochloride bulk offered by Cipla

    Find a price of Lamivudine bulk offered by Cipla

    Find a price of Leflunomide bulk offered by Cipla

    Find a price of Levalbuterol Tartrate bulk offered by Cipla

    Find a price of Levofloxacin Hemihydrate bulk offered by Cipla

    Find a price of Linagliptin bulk offered by Cipla

    Find a price of Lorazepam bulk offered by Cipla

    Find a price of Metaproterenol Hemisulfate bulk offered by Cipla

    Find a price of Methocarbamol bulk offered by Cipla

    Find a price of Metoprolol Tartrate bulk offered by Cipla

    Find a price of Montelukast Sodium bulk offered by Cipla

    Find a price of Moxifloxacin Hydrochloride bulk offered by Cipla

    Find a price of Mycophenolate Mofetil bulk offered by Cipla

    Find a price of Nifedipine bulk offered by Cipla

    Find a price of Ofloxacin bulk offered by Cipla

    Find a price of Olanzapine bulk offered by Cipla

    Find a price of Olmesartan Medoxomil bulk offered by Cipla

    Find a price of Omeprazole Sodium bulk offered by Cipla

    Find a price of Oseltamivir Phosphate bulk offered by Cipla

    Find a price of Paclitaxel bulk offered by Cipla

    Find a price of Pantoprazole Sodium bulk offered by Cipla

    Find a price of Pemetrexed Disodium bulk offered by Cipla

    Find a price of Perindopril Erbumine bulk offered by Cipla

    Find a price of Podophyllotoxin bulk offered by Cipla

    Find a price of Pomalidomide bulk offered by Cipla

    Find a price of Praziquantel bulk offered by Cipla

    Find a price of Propranolol Hydrochloride bulk offered by Cipla

    Find a price of Quetiapine Hemifumarate bulk offered by Cipla

    Find a price of Rabeprazole Sodium bulk offered by Cipla

    Find a price of Raloxifene Hydrochloride bulk offered by Cipla

    Find a price of Ranolazine bulk offered by Cipla

    Find a price of Risperidone bulk offered by Cipla

    Find a price of Rivastigmine Tartrate bulk offered by Cipla

    Find a price of Rosiglitazone Maleate bulk offered by Cipla

    Find a price of Salmeterol Xinafoate bulk offered by Cipla

    Find a price of Sibutramine Hydrochloride bulk offered by Cipla

    Find a price of Stavudine bulk offered by Cipla

    Find a price of Tamsulosin bulk offered by Cipla

    Find a price of Tegafur bulk offered by Cipla

    Find a price of Telmisartan bulk offered by Cipla

    Find a price of Tenofovir bulk offered by Cipla

    Find a price of Terbinafine Hydrochloride bulk offered by Cipla

    Find a price of Terbutaline Sulfate bulk offered by Cipla

    Find a price of Testosterone bulk offered by Cipla

    Find a price of Ticagrelor bulk offered by Cipla

    Find a price of Topotecan Hydrochloride bulk offered by Cipla

    Find a price of Torsemide bulk offered by Cipla

    Find a price of Trioxsalen bulk offered by Cipla

    Find a price of UNII-B7XF2TD73C bulk offered by Cipla

    Find a price of Valsartan bulk offered by Cipla

    Find a price of Vortioxetine Hydrobromide bulk offered by Cipla

    Find a price of Zaleplon bulk offered by Cipla

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PATALGANGA, INDIA. bulk offered by Cipla

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN KURKUMBH, INDIA. bulk offered by Cipla

    Find a price of PROPANOLOL HCl bulk offered by Cipla

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT VIKHROLI, INDIA bulk offered by Cipla

    Find a price of FACILITIES, CONTROLS AND OPERATING PROC. AT BOMBAY, INDIA bulk offered by Cipla

    Find a price of FACILITIES, CONTROLS, AND OPERATING PROC. AT BANGALORE, INDIA bulk offered by Cipla

    Find a price of Amlodipine Besylate bulk offered by Cipla

    Find a price of Anagrelide Hydrochloride bulk offered by Cipla

    Find a price of Apalutamide bulk offered by Cipla

    Find a price of Apremilast bulk offered by Cipla

    Find a price of Axitinib bulk offered by Cipla

    Find a price of Baricitinib bulk offered by Cipla

    Find a price of Bictegravir bulk offered by Cipla

    Find a price of Cetirizine Dihydrochloride bulk offered by Cipla

    Find a price of CID 69349199 bulk offered by Cipla

    Find a price of CID 9873495 bulk offered by Cipla

    Find a price of Crisaborole bulk offered by Cipla

    Find a price of Deferasirox bulk offered by Cipla

    Find a price of Dexlansoprazole bulk offered by Cipla

    Find a price of Erlotinib Hydrochloride bulk offered by Cipla

    Find a price of Everolimus bulk offered by Cipla

    Find a price of Favipiravir bulk offered by Cipla

    Find a price of Fenbendazole bulk offered by Cipla

    Find a price of Fluconazole bulk offered by Cipla

    Find a price of Glatiramer Acetate bulk offered by Cipla

    Find a price of Glycopyrronium Bromide bulk offered by Cipla

    Find a price of Granisetron bulk offered by Cipla

    Find a price of Ibandronate Sodium bulk offered by Cipla

    Find a price of Lenalidomide bulk offered by Cipla

    Find a price of Lenvatinib bulk offered by Cipla

    Find a price of Levocetirizine Dihydrochloride bulk offered by Cipla

    Find a price of Lifitegrast bulk offered by Cipla

    Find a price of Meloxicam bulk offered by Cipla

    Find a price of Palbociclib bulk offered by Cipla

    Find a price of Pioglitazone bulk offered by Cipla

    Find a price of Ribociclib bulk offered by Cipla

    Find a price of Sacubitril-Valsartan bulk offered by Cipla

    Find a price of Sitagliptin Hydrochloride bulk offered by Cipla

    Find a price of Sitagliptin Phosphate bulk offered by Cipla

    Find a price of Sofosbuvir bulk offered by Cipla

    Find a price of Sugammadex Sodium bulk offered by Cipla

    Find a price of Topiramate bulk offered by Cipla

    Find a price of Vildagliptin bulk offered by Cipla

    Find a price of Pantoprazole sodium sesquihydrate anhydrous bulk offered by Cipla

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search